RP1 rs121908741: Understanding the p.Arg677Ter Variant
The rs121908741 variant in the RP1 gene is a well-documented pathogenic mutation known as p.Arg677Ter. It is strongly associated with autosomal dominant retinitis pigmentosa, a condition characterized by progressive vision loss.
What each genotype means
Typical retinal risk
You carry two copies of the common reference allele at this position in the RP1 gene. This genotype is not associated with the nonsense truncating mutation (p.Arg677Ter) linked to inherited retinal dystrophy. It confers the standard population baseline risk for vision changes associated with this specific locus.
Carried by more than 99.9% of individuals across all major global populations.
Increased retinitis pigmentosa risk
You carry one copy of the pathogenic nonsense variant (p.Arg677Ter, also noted as R677X) in the RP1 gene. In clinical genetics, this truncating alteration is strongly associated with autosomal dominant retinitis pigmentosa, a condition causing progressive night and peripheral vision loss. Because clinical expression and age of onset can vary widely among individuals, this genetic finding represents an elevated risk rather than a definitive diagnosis.
Extremely rare globally, occurring in fewer than 1 in 1,000 individuals, but found as a recurring cause in 3% to 8% of autosomal dominant retinitis pigmentosa families.
High retinitis pigmentosa risk
You carry two copies of the truncating nonsense mutation in the RP1 gene. Because a single copy is sufficient to cause autosomal dominant retinitis pigmentosa, carrying two mutated copies is predicted to cause retinal dystrophy with severe, early-onset photoreceptor degeneration. Published literature on homozygous individuals is extraordinarily sparse due to the extreme rarity of the variant.
Extremely rare worldwide, estimated at far less than 1 in 1,000,000 individuals across all populations.
What is the rs121908741 Variant?
The variant rs121908741, often referred to in scientific literature as p.Arg677Ter or R677X, is a specific change in the DNA sequence of the RP1 gene. Located on chromosome 8, this variant is classified as a nonsense mutation. A nonsense mutation occurs when a single nucleotide change creates a premature stop signal in the genetic code. This signal instructs the cell to stop building the protein prematurely, resulting in a truncated, or shortened, version of the RP1 protein. Because the protein is incomplete, it often cannot perform its normal biological functions within the cell. This specific variant has been extensively studied since its identification in the late 1990s and is recognized as a significant genetic factor in the development of certain inherited retinal conditions.
The Role of the RP1 Gene
The RP1 gene provides instructions for making a protein that is primarily expressed in the photoreceptor cells of the retina, the light-sensitive tissue at the back of the eye. This protein is a microtubule-associated protein that plays a critical role in the structural integrity and organization of the photoreceptor outer segments. These outer segments are essential for capturing light and converting it into electrical signals that the brain interprets as vision. By helping to orient and stack the discs within these segments, the RP1 protein ensures that photoreceptors function correctly. When the RP1 protein is absent or dysfunctional due to mutations like rs121908741, the photoreceptor cells may degenerate over time, leading to the progressive vision loss observed in retinitis pigmentosa.
Research and Clinical Associations
Research has consistently associated the p.Arg677Ter mutation with autosomal dominant retinitis pigmentosa (adRP). Studies indicate that this specific mutation is one of the most common causes of adRP, accounting for a notable percentage of cases in various populations. The evidence for its pathogenicity is strong, with multiple clinical submissions to databases like ClinVar classifying it as pathogenic. It is important to note that while the genetic cause is identified, the clinical expression of the disease can vary significantly between individuals, even those within the same family. Factors such as other genetic modifiers, environmental influences, and allelic heterogeneity may contribute to these differences in visual field loss and retinal function. This variability underscores the complexity of the condition and the importance of clinical evaluation.
Population Frequency and Prevalence
The rs121908741 variant is considered rare in the general population, with a minor allele frequency (MAF) typically reported as less than 0.001 globally. Because it is a rare, pathogenic variant, it is not commonly found in the general healthy population. Its presence is primarily identified in clinical settings among individuals or families presenting with symptoms of retinitis pigmentosa. Due to its rarity, large-scale population studies often show very few carriers. The identification of this variant is usually the result of targeted genetic testing for individuals experiencing symptoms of retinal dystrophy, rather than routine population screening. Its rarity highlights that while it is a significant cause of disease for those who carry it, it is not a common variation found in the broader human gene pool.
Navigating Genetic Information
Understanding a genetic variant like rs121908741 is a complex process that should always be conducted in consultation with healthcare professionals. If you or a family member have received a report identifying this variant, it is essential to discuss the findings with a genetic counselor or an ophthalmologist specializing in inherited retinal diseases. These professionals can provide context regarding the specific implications for your health, potential disease progression, and available management strategies. It is important to remember that genetic information is only one piece of the puzzle; clinical examinations, such as optical coherence tomography (OCT) and electroretinography (ERG), are vital for assessing actual retinal health. Never use genetic data to self-diagnose or make medical decisions without professional guidance, as clinical management must be tailored to the individual's specific health history.
How common is this variant?
The rs121908741 variant is rare, with a global minor allele frequency of less than 0.001.
Frequently asked questions
What is the clinical significance of the RP1 p.Arg677Ter mutation?
The p.Arg677Ter mutation is a pathogenic variant in the RP1 gene that is a known cause of autosomal dominant retinitis pigmentosa. It leads to the production of a truncated protein that disrupts photoreceptor function.
Is the rs121908741 variant inherited?
Yes, this variant is inherited in an autosomal dominant pattern. This means that an individual only needs to inherit one copy of the mutated gene from an affected parent to be at risk for the condition.
Can I be tested for the rs121908741 variant?
Genetic testing for specific variants is typically performed in a clinical setting, often ordered by an ophthalmologist or geneticist. You should discuss the necessity and implications of such testing with your healthcare provider.
Does having this variant guarantee vision loss?
While this variant is strongly associated with retinitis pigmentosa, the severity and rate of vision loss can vary between individuals. Clinical factors and genetic modifiers play a role in how the condition manifests.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908741?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RP1
Pathogenic variants in the RP1 gene are a well-established cause of autosomal dominant retinitis pigmentosa, leading to progressive photoreceptor degeneration and vision loss.
Carries the Arg677STOP truncating mutation in RP1, accounting for up to 5% of autosomal dominant retinitis pigmentosa in European-derived populations.
A well-characterized missense substitution in RP1 implicated in inherited retinal degeneration and forms of retinitis pigmentosa.
Well-characterized nonsense/truncating variant in RP1 linked to autosomal dominant retinitis pigmentosa.
A nonsense variant (p.Arg677Ter) in RP1 causing autosomal dominant retinitis pigmentosa.
This variant in the RP1 gene is associated with autosomal dominant retinitis pigmentosa, causing progressive night blindness and peripheral field loss.